research on semaglutide as a GLP-1 Agonist: A Breakthrough in Obesity Treatment Semaglutide Market Size, Share &

But now, the scale has stalled

Talking about any changes with your doctor can help adjust your treatment

We offer the ability for providers and organizations to choose white-labeled kitting to reach patients for ongoing medication adherence through remote testing

Efficacy and Safety of the Once-Weekly GLP-1 Receptor Agonist Albiglutide Versus Sitagliptin in Patients With Type 2 Diabetes and Renal Impairment: A Randomized Phase III Study

For instance, while most GLP-1 medications are typically prescribed for treating type 2 diabetes, semaglutide and tirzepatide can be safely used by anyone (regardless of diabetes status) for significant weight loss